1. Home
  2. ELEV vs ATER Comparison

ELEV vs ATER Comparison

Compare ELEV & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • ATER
  • Stock Information
  • Founded
  • ELEV 2019
  • ATER 2014
  • Country
  • ELEV United States
  • ATER United States
  • Employees
  • ELEV N/A
  • ATER N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • ELEV Health Care
  • ATER Consumer Discretionary
  • Exchange
  • ELEV Nasdaq
  • ATER Nasdaq
  • Market Cap
  • ELEV 18.1M
  • ATER 15.5M
  • IPO Year
  • ELEV 2021
  • ATER N/A
  • Fundamental
  • Price
  • ELEV $0.32
  • ATER $1.43
  • Analyst Decision
  • ELEV Buy
  • ATER
  • Analyst Count
  • ELEV 6
  • ATER 0
  • Target Price
  • ELEV $2.94
  • ATER N/A
  • AVG Volume (30 Days)
  • ELEV 753.5K
  • ATER 166.9K
  • Earning Date
  • ELEV 08-05-2025
  • ATER 05-14-2025
  • Dividend Yield
  • ELEV N/A
  • ATER N/A
  • EPS Growth
  • ELEV N/A
  • ATER N/A
  • EPS
  • ELEV N/A
  • ATER N/A
  • Revenue
  • ELEV N/A
  • ATER $94,191,000.00
  • Revenue This Year
  • ELEV N/A
  • ATER N/A
  • Revenue Next Year
  • ELEV N/A
  • ATER $7.48
  • P/E Ratio
  • ELEV N/A
  • ATER N/A
  • Revenue Growth
  • ELEV N/A
  • ATER N/A
  • 52 Week Low
  • ELEV $0.22
  • ATER $1.36
  • 52 Week High
  • ELEV $3.77
  • ATER $3.84
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 49.38
  • ATER 31.95
  • Support Level
  • ELEV $0.29
  • ATER $1.59
  • Resistance Level
  • ELEV $0.32
  • ATER $1.54
  • Average True Range (ATR)
  • ELEV 0.02
  • ATER 0.12
  • MACD
  • ELEV 0.00
  • ATER -0.03
  • Stochastic Oscillator
  • ELEV 59.01
  • ATER 14.29

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: